ICD-10-CM 2027 diagnosis code
Z03.810Encounter for observation for suspected exposure to anthrax ruled out
Z03.810 is a valid, billable ICD-10-CM code for encounter for observation for suspected exposure to anthrax ruled out. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Encntr for obs for suspected exposure to anthrax ruled out
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About Z03.810
Z03.810 is the ICD-10-CM diagnosis code for encounter for observation for suspected exposure to anthrax ruled out. It belongs to category Z03 (encounter for medical observation for suspected diseases and conditions ruled out), block Z00-Z13 (persons encountering health services for examinations) and chapter 21 (factors influencing health status and contact with health services). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within Z03.81 (encounter for observation for suspected exposure to biological agents ruled out), Z03.810 is specifically for encounter for observation for suspected exposure to anthrax ruled out. Related codes cover other biological agents ruled out (Z03.818).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 951 (Other Factors Influencing Health Status, relative weight 0.5577), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as V71.82 (observation and evaluation for suspected exposure to anthrax).
Notes that apply from higher levels
Instructions written at a parent level also apply to Z03.810.
› From Z03 Encounter for medical observation for suspected diseases and conditions ruled out
Broader instructions also apply from Z00-Z13 Persons encountering health services for examinations and Chapter 21: Factors influencing health status and contact with health services.
Alphabetic index entries
3 entriesTerms in the official ICD-10-CM index that lead to Z03.810.
- Encounter (with health service) (for) › observation (for) (ruled out) › exposure to (suspected) › anthrax
- Encounter (with health service) (for) › suspected exposure (to), ruled out › anthrax
- Observation (following) (for) (without need for further medical care) › suspected, ruled out › exposure (to) › anthrax
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 23 · Factors Influencing Health Status and Other Contacts with Health Services
ICD-9-CM equivalent
Converter →- V71.82Observation and evaluation for suspected exposure to anthraxexact
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about Z03.810
Is Z03.810 billable?
- Yes. Z03.810 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can Z03.810 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict Z03.810 as a principal diagnosis.
Is Z03.810 a CC or MCC?
- No. Z03.810 is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does Z03.810 group to?
- Z03.810 is used in the MS-DRG v44.0 logic for MS-DRG 951 (Other Factors Influencing Health Status). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.